|
ÇÁ·Î±×·¥
|
¡Ø ¼¼ºÎÀÏÁ¤Àº »çÁ¤»ó º¯°æµÉ ¼ö ÀÖ½À´Ï´Ù.
|
1ÀÏÂ÷ (7¿ù 15ÀÏ, ¿ù) Prologue |
½Ã°£ |
ÁÖÁ¦ ¹× ³»¿ë |
¿¬ÀÚ |
14:00 ~ 14:40 |
Welcome Ceremony Ä·ÇÁ Program Overview (Ä·ÇÁ staff ¼Ò°³ / Âü°¡ÀÚ ¼Ò°³) |
½ÅÀç±¹ ±³¼ö (ºÎ»ê¹éº´¿ø ÀÓ»ó¾à¸®Çаú) |
14:40 ~ 15:30 |
Era of 4 P Medicine (Personalized, Predictive, Preventive and Participatory) |
½ÅÀç±¹ ±³¼ö (ºÎ»ê¹éº´¿ø ÀÓ»ó¾à¸®Çаú) |
15:40 ~ 16:20 |
¸ÂÃãÄ¡·á ½Ã´ë¿¡ ³ªÀÇ ¾à¹°À¯ÀüÇü ¾Ë¾Æº¸±â (µ¿ÀǼ ¼³¸í ¹× äÇ÷) |
±èÀº¿µ ±³¼ö (ºÎ»ê¹éº´¿ø ÀÓ»ó¾à¸®Çаú) |
16:30 ~ 17:20 |
¼±¹è°¡ ¹Ù¶óº¸´Â ÀÇ°úÇÐÀÚÀÇ ±æ |
ÇѽÂÈÆ ±³¼ö (°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ) |
17:20 ~ 18:10 |
Group Discussion I : Project ¼³¸í ¹× Presentation Plan Â¥±â |
Mentors |
19:00 ~ |
ȯ¿µ¸¸Âù |
|
2ÀÏÂ÷ (7¿ù 16ÀÏ, È) New drug development process |
½Ã°£ |
ÁÖÁ¦ ¹× ³»¿ë |
¿¬ÀÚ |
09:00 ~ 09:50 |
½Å¾à°³¹ß ¹°Áú µµÃâ °úÁ¤ ¹× ½Å¾àÈĺ¸¹°ÁúÀÇ ¾à¹°µ¿Å ¿¬±¸ (In Vitro ADME & Toxicology study) |
±èµ¿Çö ±³¼ö (ÀÎÁ¦ÀÇ´ë ¾à¸®Çб³½Ç) |
10:00 ~ 10:50 |
½Å¾à°³¹ß ÀÓ»ó½ÃÇè °³¿ä ¹× °úÁ¤ |
½É¾ðÁ¤ ±³¼ö (ÀÎÁ¦ÀÇ´ë ¾à¸®Çб³½Ç) |
11:00 ~ 11:50 |
In Silico: Beyond Medical Textbooks |
±èÁ¾·ü ±³¼ö (ºÎ»ê¹éº´¿ø ÀÓ»ó¾à¸®Çаú) |
12:00 ~ 13:50 |
CTC Åõ¾î ¹× Áᫎ |
½É¾ðÁ¤/±è¼Ò¿ø (ÀÎÁ¦ÀÇ´ë ¾à¸®Çб³½Ç) |
14:00 ~ 15:30 |
PGRC/BMRC Tour À¯ÀüÇü ºÐ¼® ½Ç½À I (Genomic DNA ºÐ¸® ¹× PCR) |
½Ç½ÀÁ¶±³ (¾à¹°À¯ÀüÇüºÐ¼®ÆÀ) |
15:30 ~ 15:50 |
Break |
|
15:50 ~ |
Group Discussion II: Team Meet with Mentors to Brainstorm Ideas for The Team's Plan
|
Mentors |
3ÀÏÂ÷ (7¿ù 17ÀÏ, ¼ö) Pharmacogenomics-based personalized medicine |
½Ã°£ |
ÁÖÁ¦ ¹× ³»¿ë |
¿¬ÀÚ |
09:00 ~ 09:50 |
¾à¹°À¯Àüü ¿¬±¸ °³¿ä ¹× Áø´Ü±â¼ú |
ÀÌ»ó¼· ±³¼ö (ÀÎÁ¦ÀÇ´ë ¾à¸®Çб³½Ç) |
10:00 ~ 10:50 |
¹Ì·¡ÀÇÇÐÀÇ ÇöÁÖ¼Ò: ¾à¹°À¯Àüü ¸ÂÃãÄ¡·áÀÇ ÀÓ»óÀû¿ë»ç·Ê |
±èÈ£¼÷ ±³¼ö (ÀÎÁ¦ÀÇ´ë ¾à¸®Çб³½Ç) |
11:00 ~ 11:50 |
ÀǾàÇ° ¹× ¾à¹°À¯Àüü Á¤º¸ |
ÀÓ¿µÇØ °úÀå (ºÎ»ê¹éº´¿ø ¾àÁ¦ºÎ) |
12:00 ~ 13:00 |
Áᫎ |
|
13:00 ~ 17:00 |
À¯ÀüÇü ºÐ¼® ½Ç½À II (SNaPshot analysis) |
½Ç½ÀÁ¶±³ (¾à¹°À¯ÀüÇüºÐ¼®ÆÀ) |
17:00 ~ 17:20 |
Break |
|
17:20 ~ |
Group Discussion III: Discussion and Development of a Project Proposal |
Mentors |
4ÀÏÂ÷ (7¿ù 18ÀÏ, ¸ñ) Scope of Clinical pharmacology |
½Ã°£ |
ÁÖÁ¦ ¹× ³»¿ë |
¿¬ÀÚ |
09:00 ~ 09:50 |
ÀÓ»ó¾à¸®ÇÐÀÚÀÇ ¿ªÇÒ |
½ÅÀç±¹ ±³¼ö (ºÎ»ê¹éº´¿ø ÀÓ»ó¾à¸®Çаú) |
10:00 ~ 10:50 |
Pharmacovigilance Practice |
±è¹Ì¿µ ±³¼ö (ºÎ»ê¹éº´¿ø È£Èí±â³»°ú) |
11:00 ~ 11:50 |
½Å¾à°³¹ß°úÁ¤¿¡¼ ÀÇ·áÀü¹®°¡ÀÇ ¿ªÇÒ, ºñÀü, öÇÐ |
±è¸íÈÆ (Á¦¾àÀÇÇÐȸ ȸÀå) |
12:00 ~ 13:30 |
Áᫎ |
|
13:30 ~ 14:30 |
À¯ÀüÇü ºÐ¼® ½Ç½À III (À¯ÀüÇü È®ÀÎ) |
±èÀº¿µ ±³¼ö (ºÎ»ê¹éº´¿ø ÀÓ»ó¾à¸®Çаú) |
14:30 ~ 15:00 |
Break |
|
15:00 ~ 15:30 |
Presentation Áغñ / ¼³¹®Áö ÀÛ¼º |
|
15:30 ~ 18:00 |
Group Discussion Final : Presentation Áغñ |
|
5ÀÏÂ÷ (7¿ù 19ÀÏ, ±Ý) Epilogue |
½Ã°£ |
ÁÖÁ¦ ¹× ³»¿ë |
¿¬ÀÚ |
09:00 ~ 12:00 |
Group Presentation |
°¢ ÆÀº° 30ºÐ ¹ßÇ¥ (20ºÐ ¹ßÇ¥ / 10ºÐ ÁúÀÇ ÀÀ´ä) |
12:00 ~ 13:30 |
Áᫎ |
|
13:30 ~ 18:00 |
Social Program |
|
18:30 ~ |
¼Ûº° ¸¸Âù: Æóȸ½Ä ¹× ½Ã»ó½Ä |
|
|
|